Globus Medical (GMED) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among
Elo Mutual Pension Insurance Co grew its stake in shares of Globus Medical, Inc. (NYSE: GMED) by 106.2% in the third quarter, according to the company in its most recent filing with the SEC. The firm
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
GMED gains share in musculoskeletal solutions with spine growth, rapid product launches and strong cash, but macro headwinds and rising costs remain risks.
Globus Medical (GMED) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

New Strong Buy Stocks for March 4th

06:11am, Wednesday, 04'th Mar 2026
ORN, LRCX, GMED, MYRG and CPRX have been added to the Zacks Rank #1 (Strong Buy) List on March 4, 2026.
GE stock is among this list of fast-growers that haven't lost momentum.
While the top- and bottom-line numbers for Globus Medical (GMED) give a sense of how the business performed in the quarter ended December 2025, it could be worth looking at how some of its key metrics
Globus Medical (GMED) came out with quarterly earnings of $1.28 per share, beating the Zacks Consensus Estimate of $1.06 per share. This compares to earnings of $0.84 per share a year ago.
Globus Medical, Inc. (GMED) Q4 2025 Earnings Call Transcript
AUDUBON, Pa., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology solutions company, today announced its financial results for the fourth quarter

Breakfast News: Is AI A "Datadog-Killer"?

07:30am, Tuesday, 24'th Feb 2026
Datadog gets hit on AI disruption fears, Whirlpool pushes $800 million stock offering, and more
Investors looking for stocks in the Medical - Instruments sector might want to consider either Globus Medical (GMED) or Masimo (MASI). But which of these two stocks is more attractive to value investo
Globus Medical, Inc. (NYSE: GMED - Get Free Report) EVP Kelly Huller sold 10,000 shares of the company's stock in a transaction that occurred on Thursday, February 12th. The shares were sold at an ave
Beyond analysts' top-and-bottom-line estimates for Globus Medical (GMED), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the q
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE